Royal Philips announces that its Lumify handheld point-of-care ultrasound system now offers U.S. FDA 510(k)-cleared hemodynamic assessment and measurement capabilities. With this latest addition of Pulse Wave Doppler, Philips handheld ultrasound enables clinicians to quantify blood flow in a wide range of point-of-care diagnostic applications—including cardiology, vascular, abdominal, urology, obstetrics and gynecology. 

Upgrades to Lumify also include obstetric measurements to help in early assessment of gestational age and the identification of high-risk pregnancies.

Point-of-Care Hemodynamics

Pulse Wave Doppler ultrasound allows clinicians to diagnose in critical situations beyond 2D and color imaging to assess hemodynamic patterns to differentiate between arterial and venous blood flow and quantify hemodynamic function. 

The resulting hemodynamic measurements can enhance diagnostic confidence and clinical decision-making in care settings including cardiology and emergency medicine. The Lumify system also provides clinicians with advanced analysis software and reporting tools, and access to tele-ultrasound capabilities (Lumify with Reacts) for live communication support to connect clinicians around the globe for real-time collaboration. 

“By applying Philips’ leading cardiovascular, imaging, and patient monitoring expertise to Lumify, we are committed to deliver a dedicated point-of-care innovative portfolio, enabling clinicians to quickly assess hemodynamics—including cardiovascular function, organ perfusion and assessing health of a fetus—in a daily routine, to identify abnormalities and intervene quickly,” says Matthijs Groot Wassink, general manager of point-of-care ultrasound at Philips. 

“With the addition of Pulse Wave Doppler and enhanced obstetrics measurements, we have significantly increased the number of markers on which diagnoses can be made, to deliver high quality imaging and enhance the evaluation and effectiveness of treatment in real-time,” he adds. 

Robert Jones, MD, professor of emergency medicine at the Cleveland-based MetroHealth System, also spoke out about the product, commenting: “Having Color Flow Doppler and Pulse Wave Doppler on a handheld device is game-changing, allowing clinicians to take point-of-care ultrasound examinations to the next level.”